ArticleMolecular therapy. Nucleic acids2022

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies.

Amy Easton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.